Joseph S Mccracken - Net Worth and Insider Trading

Joseph S Mccracken Net Worth

The estimated net worth of Joseph S Mccracken is at least $665,773 dollars as of 2024-06-07. Joseph S Mccracken is the Director of Savara Inc and owns about 168,337 shares of Savara Inc (SVRA) stock worth over $665,773. Details can be seen in Joseph S Mccracken's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph S Mccracken has not made any transactions after 2021-03-15 and currently still holds the listed stock(s).

Transaction Summary of Joseph S Mccracken

Joseph S Mccracken Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph S Mccracken owns 4 companies in total, including Lumos Pharma Inc (LUMO) , Kindred Biosciences Inc (KIN) , and Savara Inc (SVRA) among others .

Click here to see the complete history of Joseph S Mccracken’s form 4 insider trades.

Insider Ownership Summary of Joseph S Mccracken

Ticker	Comapny	Transaction Date	Type of Owner
LUMO	Lumos Pharma Inc	2020-03-23	director
KIN	Kindred Biosciences Inc	2020-01-17	director
SVRA	Savara Inc	2021-03-15	director
		2017-07-31	director

Joseph S Mccracken Latest Holdings Summary

Joseph S Mccracken currently owns a total of 1 stock. Joseph S Mccracken owns 168,337 shares of Savara Inc (SVRA) as of March 15, 2021, with a value of $665,773.

Latest Holdings of Joseph S Mccracken

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SVRA	Savara Inc	2021-03-15	168,337	3.96	665,773

Holding Weightings of Joseph S Mccracken

Joseph S Mccracken Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph S Mccracken has made a total of 1 transactions in Savara Inc (SVRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Savara Inc is the acquisition of 68,965 shares on March 15, 2021, which cost Joseph S Mccracken around $99,999.

Insider Trading History of Joseph S Mccracken

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph S Mccracken Trading Performance

GuruFocus tracks the stock performance after each of Joseph S Mccracken's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph S Mccracken is 14.99%. GuruFocus also compares Joseph S Mccracken's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph S Mccracken within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joseph S Mccracken's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joseph S Mccracken

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	3.7
Relative Return to S&P 500(%)	1.33

Joseph S Mccracken Ownership Network

Ownership Network List of Joseph S Mccracken

No Data

Ownership Network Relation of Joseph S Mccracken

Joseph S Mccracken Owned Company Details

What does Lumos Pharma Inc do?

Who are the key executives at Lumos Pharma Inc?

Joseph S Mccracken is the director of Lumos Pharma Inc. Other key executives at Lumos Pharma Inc include Chief Medical Officer David B Karpf , Chief Business Officer Aaron Schuchart , and 10 percent owner & other: Possible Member of 10% Group James E Flynn .

Lumos Pharma Inc (LUMO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Lumos Pharma Inc (LUMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lumos Pharma Inc (LUMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Lumos Pharma Inc (LUMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lumos Pharma Inc Insider Transactions

No Available Data

What does Kindred Biosciences Inc do?

Who are the key executives at Kindred Biosciences Inc?

Joseph S Mccracken is the director of Kindred Biosciences Inc. Other key executives at Kindred Biosciences Inc include director & Chief Executive Officer Richard Chin , 10 percent owner Park West Asset Management Llc , and Chief Financial Officer Wendy Wee .

Kindred Biosciences Inc (KIN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kindred Biosciences Inc (KIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kindred Biosciences Inc (KIN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kindred Biosciences Inc (KIN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kindred Biosciences Inc Insider Transactions

No Available Data

What does Savara Inc do?

Who are the key executives at Savara Inc?

Joseph S Mccracken is the director of Savara Inc. Other key executives at Savara Inc include Chief Financial Officer David L Lowrance , 10 percent owner Rick Yang , and 10 percent owner Forest Baskett .

Savara Inc (SVRA) Insider Trades Summary

Over the past 18 months, Joseph S Mccracken made no insider transaction in Savara Inc (SVRA). Other recent insider transactions involving Savara Inc (SVRA) include a net purchase of 218,890 shares made by David A Ramsay , a net purchase of 10,000 shares made by Raymond Dennis Pratt , and a net purchase of 333,333 shares made by Mohamad Makhzoumi .

In summary, during the past 3 months, insiders sold 0 shares of Savara Inc (SVRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 187,843 shares of Savara Inc (SVRA) were sold and 3,562,220 shares were bought by its insiders, resulting in a net purchase of 3,374,377 shares.

Savara Inc (SVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Savara Inc Insider Transactions

No Available Data

What does Nexvet Biopharma PLC do?

Who are the key executives at Nexvet Biopharma PLC?

Joseph S Mccracken is the director of Nexvet Biopharma PLC. Other key executives at Nexvet Biopharma PLC include 10 percent owner & other: Member of Group Owning 10% Philip D Dreyfuss , 10 percent owner & other: Member of Group Owning 10% William Seybold , and 10 percent owner & other: Member of Group Owning 10% Ravi K Paidipaty .

Nexvet Biopharma PLC (NVET) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nexvet Biopharma PLC (NVET) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nexvet Biopharma PLC (NVET) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nexvet Biopharma PLC (NVET)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nexvet Biopharma PLC Insider Transactions

No Available Data

Joseph S Mccracken Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph S Mccracken. You might contact Joseph S Mccracken via mailing address: C/o Nexvet Biopharma Plc, Natl Inst, Fosters Avenue, Mount Merrion, Blackrock L2 00000.

Discussions on Joseph S Mccracken

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.